ABM-2526

N/A

Report date: 2025/01/26 18:24:09
NME

Base Information

Drug NameABM-2526
Drug Alias NameABM-2526
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRAF serine/threonine protein kinase modulatorsEphrin type-A receptor 2 modulators
TargetsEphrin type-A receptor 2RAF serine/threonine protein kinase
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesABM Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesABM Therapeutics
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A